When drug maker Allergan came out with the new eyelash thickening drug Latisse last year, it put on a marketing blitz featuring actress Brooke Shields. The Latisse Web site showed her longer, thicker lashes from the drug.
But the site barely mentioned Latisse's nasty side effects, which can include hair growth outside of the treatment area, a permanent darkening of eye color and bacterial infections that can lead to blindness.
The Food and Drug Administration lashed out in September 2009. In an official warning letter the FDA scolded Allergan ( AGN - news -people ) for its "misleading" claims about Latisse, which it said "omit and minimize" the drug's side effects. It demanded the company fix the Web site immediately. (Más...)
http://www.forbes.com/2010/02/02/drug-advertising-lipitor-lifestyle-health-pharmace
http://pharmacoserias.blogspot.com/2007/02/fda-ten-misleading-drug-ads.html
Smoking Cessation
Copy writing : It smells different to non-smokers.Artwork & Concept: It's really a so "smelly" new idea, it show the cigar as a piece of "shit".
Ref.: www..azur.com.au for training !
Please contribute with your critique!
How to become a pharmaceutical sales person
How to Become a Pharmaceutical Salesperson -- powered by eHow.com
Top 10 health care social media predictions for 2010
Social media has been the dancing elephant in the living room of medical marketing ever since user-generated content on the Web became possible, and the furniture hasn’t stopped shaking since. But 2009 was a watershed year in terms of adoption and next steps, as pharmaceutical companies from AstraZeneca to Sanofi-Aventis explored channels from YouTube to Twitter, while in November FDA took the unprecedented step of holding a public hearing regarding use of the Internet and social media for the promotion of FDA-regulated products. The once far-fetched notion of FDA-issued Internet guidelines now looms as inevitable as it once seemed surprising.
Experts are making predictions about the exciting year ahead, unabashedly speculating if 2010 will indeed be the year the healthcare social media groundswell turns into a transformative medical marketing eruption - and whether that disruption proves to have an overall positive or negative impact on the industry. Ver...
Prediction #1: FDA will issue draft guidelines that outline how manufacturers can and should use the Internet and Social Media for FDA-regulated products by the end of 2010, infusing the channel with direction, legitimacy, and explosive activity.
Prediction #2: Google’s new “pharma-friendly” ad format, now in testing with select customers including Bayer, will propel these guidelines, revolutionize paid search, and help reinstate the “one-click rule” for fair balance information.
Prediction #3: The role of video will exponentially increase and be taken even more seriously by healthcare companies and the FDA.
Prediction #4: The role of patients and patient communities will increase and prove central to both branded and unbranded social media DTC initiatives.
Prediction #5: The role of healthcare communications agencies will increase, meaning a bigger role for social media marketers and consultants.
Prediction #6: A daring pharmaceutical company and healthcare marketing manager will score a “big win” with social media, opening the floodgates.
Prediction #7: Not only pharma, but government and health authorities will increasingly utilize social media as their preferred communication strategy.
Prediction #8: Social media will prove to be a vital internal communications tool.
Prediction #9: Social media will help nurture the physician-patient relationship.
Prediction #10: Social media will actually begin to benefit pharmaceutical companies’ own processes, tools, and technologies.
http://pharmacoserias.blogspot.com/2007/01/top-10-health-care-social-media.html
Experts are making predictions about the exciting year ahead, unabashedly speculating if 2010 will indeed be the year the healthcare social media groundswell turns into a transformative medical marketing eruption - and whether that disruption proves to have an overall positive or negative impact on the industry. Ver...
Prediction #1: FDA will issue draft guidelines that outline how manufacturers can and should use the Internet and Social Media for FDA-regulated products by the end of 2010, infusing the channel with direction, legitimacy, and explosive activity.
Prediction #2: Google’s new “pharma-friendly” ad format, now in testing with select customers including Bayer, will propel these guidelines, revolutionize paid search, and help reinstate the “one-click rule” for fair balance information.
Prediction #3: The role of video will exponentially increase and be taken even more seriously by healthcare companies and the FDA.
Prediction #4: The role of patients and patient communities will increase and prove central to both branded and unbranded social media DTC initiatives.
Prediction #5: The role of healthcare communications agencies will increase, meaning a bigger role for social media marketers and consultants.
Prediction #6: A daring pharmaceutical company and healthcare marketing manager will score a “big win” with social media, opening the floodgates.
Prediction #7: Not only pharma, but government and health authorities will increasingly utilize social media as their preferred communication strategy.
Prediction #8: Social media will prove to be a vital internal communications tool.
Prediction #9: Social media will help nurture the physician-patient relationship.
Prediction #10: Social media will actually begin to benefit pharmaceutical companies’ own processes, tools, and technologies.
http://pharmacoserias.blogspot.com/2007/01/top-10-health-care-social-media.html
Anti-Smoking Campaign
Agency: Team Young & Rubicam, Abu DhabiArt Director: Krishnagopal Kodoth
Copywriter: Mohit Raviranjan, Kaushik Bhattacharya
Graphic artist: Srinivas Sarma
Executive Creative Director: Trevor Purvis
Photographer: Abdul Nasser
Digital artist: Sumeda Rathnapala
ref.:Khaleej Times
Smoking can kill your eyesight first!
Subscribe to:
Posts (Atom)
